Understanding risk of thrombosis with thrombocytopenia syndrome after Ad26.COV2.S vaccination

Front Med. 2021 Dec;15(6):938-941. doi: 10.1007/s11684-021-0895-9. Epub 2021 Sep 30.
No abstract available

MeSH terms

  • Ad26COVS1
  • COVID-19*
  • Humans
  • SARS-CoV-2
  • Thrombocytopenia*
  • Thrombosis* / etiology
  • Thrombosis* / prevention & control
  • Vaccination

Substances

  • Ad26COVS1